Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Shanghai Henlius CEO Wants To Capitalize On First-Mover Status
Scott Liu Sets Out Ambitions That Go Beyond China
Feb 04 2020
•
By
Dave Wallace
Shanghai Henlius CEO Dr. Scott Liu says the leading Chinese biologics player will seek to capitalize on its first-mover status • Source: Shanghai Henlius Biotech
More from Strategy
More from Business